Apnimed, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
APMD Nasdaq 2834 apnimed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apnimed, Inc.

Bank of America Puts These 2 Under-the-Radar IPO Stocks on Its Buy List - Oct 6th, 2026 11:58 am
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Oct 2nd, 2026 2:05 pm
Was Moderna Stock's Cancer Vaccine Run Visible In Advance? - Sep 22nd, 2026 11:39 am
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Sep 8th, 2026 2:39 pm
BofA makes bullish call on newly public biotech stock - Aug 28th, 2026 7:03 pm
Moderna Stock Carries A Market Value Its Revenue Does Not Support - Aug 26th, 2026 9:13 am
Apnimed shares surge on bullish BofA initiation - Aug 25th, 2026 10:12 am
Moderna Stock Had A Readout Waiting In Plain Sight - Aug 24th, 2026 1:01 pm
Moderna's Melanoma Result Landed On A Market Positioned The Other Way - Aug 20th, 2026 12:21 pm
Apnimed (APMD) Joins The NASDAQ Composite Index - Aug 14th, 2026 1:12 am
Stock Market, IPO Leaders Rally To New Highs. Check This Screen Daily. - Aug 7th, 2026 7:52 am
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Aug 3rd, 2026 2:35 pm
Apnimed Announces Pricing of Upsized Initial Public Offering - Jul 30th, 2026 8:10 pm